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Abstract
Background: The blasticidin S resistance gene (bsr) is a selectable marker used for gene transfer
experiments. The bsr gene encodes for blasticidin S (BS) deaminase, which has a specific activity
upon BS. Therefore, its expression is supposed to be harmless in cells. The work reported on
herein consisted of experiments to verify a possible toxicity of bsr on mammalian cells, which
include several cell lines and primary cultures.
Results: Murine keratinocyte BALB/MK and human primary keratinocyte cells transduced with the
retroviral vector LBmSN, which has an improved expression system of bsr, namely bsrm, died in
five days after the transduction. Meanwhile the control vector LBSN, which expresses bsr, did not
provoke cell death. The lethal activity of bsrm was observed only in human keratinocytes and BALB/
MK cells among the cell types tested here. Death appears to be mediated by a factor, which is
secreted by the BALB/MK transduced cells.
Conclusion: By our study we demonstrated that the expression of bsrm gene is toxic to human
keratinocytes and BALB/MK cells. It is likely over expression of BS deaminase gene is responsible
for the death.
Background
Blasticidin S (BS) is a nucleoside antibiotic isolated from
Streptomyces griseochromogenes, and has been used as a fun-
gicide against rice blast disease [1]. BS inhibits protein
synthesis in both prokaryotes and eukaryotes [1]. Later, a
gene that provides resistance against BS (bsr) was isolated
from Bacillus cereus K55-S1 strain [2,3]. The bsr gene pos-
sesses only 420 bp [4] and codes for an enzyme of 15 kDa,
which is usually present in its dimer form [5]. The enzyme
acts upon BS converting it into a deaminohydroxy deriva-
tive [5,6], thus it is named BS deaminase.
BS antibiotic is highly toxic to mammalian cells; even 2
µg/ml is enough to kill HeLa cells in a few days. However,
the cells transfected with bsr could resist against BS at sev-
eral fold higher concentrations [7]. Hence, the BS/bsr pair
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has been used as an efficient selection system for gene
transfer experiments in many different cell types.
Recently, we reported that some modifications introduced
into the non-coding regions of the bsr gene (bsrm) resulted
in an increase (several fold) of bsr gene expression, and
consequently, NIH3T3 cells transduced by retroviral vec-
tors could be selected with higher concentrations of BS in
just a few days [8]. Even with such extensive use of the bsr/
BS selection system, no side effects in response to bsr gene
expression have been observed.
Using the murine keratinocyte cell line BALB/MK [9] and
human primary keratinocytes, we report here a surprising
death of the keratinocytes provoked by the expression of
bsrm. A detailed investigation about the death of keratino-
cytes, which was mediated by an unknown molecule and
secreted by the BALB/MK cells transduced with LBmSN, is
discussed below.
Results
Sensitivity of BALB/MK cells to BS
To determine the range of BS concentrations and the time
required for BALB/MK cell death to occur, 1 × 104 cells/
well were incubated in a 24 well plate and 2 days later the
media were replaced with a fresh one containing various
concentrations of BS for 9 days. A BS concentration of at
least 2 µg/ml was necessary to kill the cells in 5 days. At
concentrations of BS greater than 8 µg/ml the majority of
cells died within 3 days.
Effect of bsrm gene and BS on BALB/MK cells
To verify the effect of bsrm gene in BALB/MK cells, the cells
were transduced with the LBmSN retroviral vector, which
expresses the bsrm  and neoR genes, and then incubated
with BS. The bsrm gene was obtained by modifying the bsr
gene at a non-coding region and, consequently, there was
no alteration of the amino acid sequence [8]. The addition
of BS at concentrations of ≤ 4 µg/ml or 500 µg/ml of G418
to cell media resulted in the death of all transduced BALB/
MK (Figure 1G,1H,1I,1J,1K,1L,1M,1N,1O). In contrast,
the transduced cells incubated with BS at concentrations
of ≥ 8 µg/ml reached confluence within 12 days of culture
(Figs. 1P,1Q,1R). As an experimental control, BALB/MK
cells transduced with the LXSN vector (which expresses
only the neoR gene) [10] were incubated in the presence or
absence of 500 µg/ml of G418. As expected, the cells
reached partial or complete confluence within 12 days
(Figs. 1D and 1E), as also observed with the non-trans-
duced BALB/MK cells (Figure 1A).
BALB/MK cells not expressing the bsrm gene died in the
presence of 8 µg/ml of BS (Figs. 1C and 1F) as expected.
However, the aspect of the BALB/MK cells which died after
the expression of bsrm  (Figs.
1G,1H,1I,1J,1K,1L,1M,1N,1O) was different from the
aspect of the non-transduced cells (Figs. 1B and 1C) or
cells transduced with LXSN (Figure 1F) which were killed
by antibiotics alone. BALB/MK cells which died after
expressing the bsrm gene had a reduced cell volume when
compared with normal BALB/MK or transduced BALB/MK
incubated with 8 µg/ml BS (Figure 2). Additionally, the
cells, which died after bsrm expression, remained on the
plate after washing with PBS, whilst the cells killed by the
antibiotics, BS or G418, were easily removed after wash-
ing with PBS (Figure 1). The death of BALB/MK cells was
confirmed by staining with Trypane blue (Figure 1S).
Removal of BS from the medium of the cells selected with
8  µg/ml BS resulted in cell death within a week (not
shown). Thus, the BS antibiotic counteracted the death
effect of bsrm and therefore has a vital role to BALB/MK
cells transduced with LBmSN.
Effects of cell density and virus concentration upon 
induction of BALB/MK cell death
Based on the above observations two variables were ana-
lyzed to assess their influences on the cell death: virus con-
centration and cell density. The total BALB/MK cells,
transduced and non-transduced ones, were seeded at 1 ×
103 to 4 × 104 cells in 25 cm2 flasks and the cell death was
monitored by optical microscope. The flasks containing a
higher number of cells had faster cell death, even if the
ratio of virus per cell was maintained constant in all flasks
(Table 1). However, the absolute number of bsrm-trans-
duced BALB/MK cells was higher in the flasks with higher
number of seeded cells; consequently cell death was
directly related to the presence of the number of bsrm-
transduced cells.
The virus concentration used to transduce BALB/MK cells
was evaluated by infecting the cells with 1 × 102 to 1 × 105
cfu (colony forming units) of LBmSN vector. The trans-
duced cells incubated with 8 µg/ml of BS produced resist-
ant colonies proportionally to the used virus
concentration (Figure 3). LBmSN-transduced BALB/MK
cells that did not undergo selection died at all virus con-
centrations (Figs. 3G,3H,3I,3J), although the cells trans-
duced with 1 × 105 cfu died 2 days earlier than the cells
transduced with 1 × 102 to 1 × 103 cfu. This is an extremely
important observation since even in those wells contain-
ing less virus than cells (Figs. 3G and 3H) cell death
occurred simultaneously in each cell. This result suggests
the existence of intercellular signaling of death. To con-
firm this hypothesis, we seeded the LBmSN transduced
and non-transduced BALB/MK cells together with or with-
out BS (Table 2). A clear induction of death in BALB/MK
cells by the BALB/MK cells transduced with LBmSN was
observed. Changes of cell morphology in each colony
occurred within 5 days, as was seen in all experiments.BMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
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Effect of BS upon the BALB/MK cells transduced with LBmSN Figure 1
Effect of BS upon the BALB/MK cells transduced with LBmSN On day 1, BALB/MK cells were seeded on a 24-well 
plate at 1 × 104 cells/well, and 1 × 106 cells of the virus producing cell lines PA317/LBmSN (2 × 105 cfu/ml) and PA317/LXSN (5 
× 106 cfu/ml) were seeded in 25 cm2 flasks. On day 2, the media of PA317 cell clones were replaced with EMEM without EGF. 
On day 3, the media of PA317 cells containing virus were harvested, centrifuged at 10000 rpm per 1 min in Eppendorf centri-
fuge. The media of BALB/MK cells were replaced with 0.5 ml of virus solution and supplemented with 5 ng/ml EGF and 8 µg/ml 
Polybrene. On day 4, the media were replaced with fresh EMEM in the following conditions. After 12 days, the cells were 
stained with Coomassie Blue and photographed. The results are representative of at least three experiments, which gave 
essentially the same results. (A) BALB/MK; (B) BALB/MK + 500 µg/ml G418; (C) BALB/MK +  8 µg/ml BS; (D) BALB/MK/LXSN 
+ 500 µg/ml G418; (E) BALB/MK/LXSN; (F) BALB/MK/LXSN + 8 µg/ml BS; (G) BALB/MK/LBmSN; (H) BALB/MK/LBmSN + 
500 µg/ml G418; (I) BALB/MK/LBmSN + 0.05 µg/ml BS; (J) BALB/MK/LBmSN + 0.1 µg/ml BS; (K) BALB/MK/LBmSN + 0.2 µg/
ml BS; (L) BALB/MK/LBmSN + 0.5 µg/ml BS; (M) BALB/MK/LBmSN + 1 µg/ml BS; (N) BALB/MK/LBmSN + 2 µg/ml BS; (O) 
BALB/MK/LBmSN + 4 µg/ml BS; (P) BALB/MK/LBmSN + 8 µg/ml BS; (Q) BALB/MK/LBmSN + 16 µg/ml BS; (R) BALB/MK/
LBmSN + 32 µg/ml BS(S) Five days after the LBmSN transduction, the cells were detached with trypsin and stained with 
Trypan blue. Left and right sides represent BALB/MK (control) and BALB/MK/LBmSN cells respectively.BMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
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To investigate whether the death signaling is mediated by
a secreted factor, we tested the supernatant of the BALB/
MK cells transduced with LBmSN on BALB/MK cells (Fig-
ure 4). A just two-day old medium was sufficient to
induce death of normal BALB/MK cells. This result indi-
cates that cell death was mediated by a soluble factor,
secreted by the LBmSN-transduced cells, acting on both
transduced and non-transduced BALB/MK cells. This fac-
tor we denominated DOKEB (Death factor Obtained from
Keratinocytes Expressing Bsrm) to ease our discussion.
DOKEB appears to be secreted only by LBmSN-trans-
duced BALB/MK cells, because the 5 day old-medium
from the LBmSN-transduced NIH3T3 cells had no death
activity upon BALB/MK or NIH3T3 cells (data not
shown).
Effect of bsrm on mammalian cell lines
The lethal effect provoked by bsrm was firstly observed in
the murine keratinocyte cell line BALB/MK as described
above. To verify this lethal effect in other cell types, we
chose the cells originated from the skin or epithelium
(NIH3T3, HeLa, LISP-A10, LISP-E11, HCT-8 and
B16F10), because of the origin of the BALB/MK cells [11].
In addition, the rat vascular smooth muscle cells, which
are useful for gene therapy experiments [12], were also
tested.
Until 7 days post-infection none of the above cells, which
were transduced with LBmSN retroviral vector, did not
die, whereas the control cell line BALB/MK died 5 days
after the transduction (not shown). As the viral transduc-
tion rate is essential to analyze the possible death effect by
the expression of bsrm, the cells were transduced with a
ten-fold higher number of viruses than cells. Even in such
Phase contrast microscopic appearance of the BALB/MK  cells transduced with LBmSN Figure 2
Phase contrast microscopic appearance of the BALB/
MK cells transduced with LBmSN The cells were cul-
tured and transduced as described above. After 8 days of the 
transduction, the cells were photographed (X 200). The 
results are representative of at least five experiments, which 
gave essentially the same results. (A) BALB/MK; (B) BALB/
MK/LBmSN + 8 µg/ml BS; (C) BALB/MK/LBmSN
Table 1: The effect of cell density on inducing death
Cell concentration Time till cell death1 (days)
1.0 × 103 8 (0)
5.0 × 103 7 (1)
1.0 × 104 7 (0)
1.5 × 104 6 (1)
2.0 × 104 5 (1)
4.0 × 104 5 (1)
On day 1, 1 × 105 BALB/MK cells and 1 × 106 PA317/LBmSN cells 
were seeded in 25 cm2 flasks. On day 2, the medium from the PA317/
LBmSN cells was replaced with EMEM supplemented with 10 % FBS 
and without EGF. On day 3, the medium of the PA317/LBmSN cells 
containing virus was harvested, centrifuged at 10,000 rpm per 1 min in 
an Eppendorf centrifuge. The medium of the BALB/MK cells was 
replaced with 4 ml of the virus solution and complemented with EGF 
and Polybrene at a final concentration of 5 ng/ml and 8 µg/ml 
respectively. On day 4, the cells were trypsinized and seeded in the 
24 well plate at the indicated number of cells containing 8 µg/ml BS.
1 Results are the means ± S.D. of three experiments.BMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
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conditions no cell types suffered with the expression of
bsrm.
To ensure the transduction and expression of bsrm in the
cells, those transduced cells were selected with 8 µg/ml of
BS from the non-transduced ones that die in 4 days. The
selected cells were distributed to two plates, and in one
plate the initial concentration of BS was maintained and
in from the other plate the BS was removed. During the 7
days of observation no death was observed in both plates
(not shown), which confirm the previous result that the
bsrm gene is not lethal to those cell types.
We also compared death activity of LBmSN and LBSN,
which express bsrm and bsr respectively, on BALB/MK and
NIH3T3 cells. Transduction of LBSN vector on BALB/MK
or NIH3T3 cells did not cause cell death; meanwhile
LBmSN caused cell death as expected (Table 3). In the
presence of BS both cell lines transduced with LBmSN or
LBSN did not die, which is a demonstration of BS deami-
nase gene expression, and also protection of the LBmSN
transduced BLAB/MK cells against death as seen before.
These results infer that over expression of BS deaminase
gene could be responsible for the death of BALB/MK cells
expressing bsrm.
Effect of the BS analogs on BALB/MK cells
The analogs of BS, cytidine, 5'-deoxycytidine, uridine and
5'-deoxyuridine, were tested in the culture of the BALB/
MK cells transduced with LBmSN at 1 µM to 10 mM con-
centrations (Figure 4). Interestingly all analogs with 10
The effect of the concentration of the virus LBmSN upon BALB/MK cells Figure 3
The effect of the concentration of the virus LBmSN upon BALB/MK cells The cells were cultured and transduced as 
described in Figure 1, however the virus concentration in each plate varied as follows. After 10 days of the transduction, the 
cells were stained with Coomassie Blue and photographed. The results are representative of at least three experiments, which 
gave essentially the same results. (A) BALB/MK + 8 µg/ml BS; (B) BALB/MK + 102 cfu of LBmSN + 8 µg/ml BS; (C) BALB/MK + 
103 cfu of LBmSN + 8 µg/ml BS; (D) BALB/MK + 104 cfu of LBmSN + 8 µg/ml BS; (E) BALB/MK + 105 cfu of LBmSN + 8 µg/ml 
BS; (F) BALB/MK; (G) BALB/MK + 102 cfu of LBmSN; (H) BALB/MK + 103 cfu of LBmSN; (I) BALB/MK + 104 cfu of LBmSN; (J) 
BALB/MK + 105 cfu of LBmSN
Table 2: Effect of the BALB/MK cells expressing bsrm upon 
BALB/MK cells
BALB/MK BALB/MK/LBmSN BS1 EFFECT
++ - D
++ + L
-+ - D
-+ + L
+- - L
Both cell lines, BALB/MK and BALB/MK/LBmSN, were seeded in a 24 
well plate at 1 × 104 of each one/well or 2 × 104 cells of one cell line/
well. Two days later, the media were replaced by fresh ones, and after 
6 days the cells were stained with Coomassie Blue for microscopic 
analysis. The results are representative of at least two experiments, 
which gave essentially the same results.
1 [BS] = 8 µg/ml
D = dead
L = alive
+ = presence
- = absenceBMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
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mM protected the transduced cells during 5 days of obser-
vation. Changing the medium with a fresh one containing
10 mM of each analog at every five days, the cells could be
maintained alive for several passages (not shown).
Effect of the bsrm gene and BS upon human keratinocytes
The transduced human keratinocytes, which were modi-
fied with the virus producing cell clone PA317/LBmSN as
a feeder-layer, did not grow during 8 days of culture in the
absence of BS (Figure 6). Incubating the transduced kerat-
inocytes with BS at 0.05 to 2 µg/ml, which are tolerant
concentrations by the cells, also resulted in the absence of
cell growth (not shown). However, the presence of 8 µg/
ml of antibiotic, in the medium, which is a lethal concen-
tration for the cells, resulted in the formation of many
keratinocyte colonies. The number of these BS resistant
colonies decreased as the BS concentration increased (Fig-
ure 6).
The BS selected cells could be maintained alive even with
the expression of bsrm if the medium is replaced every two
days with a fresh one containing the initial concentration
of BS. Nevertheless, if those cells were seeded on a new
Effect of analogs of BS upon BALB/MK cells transduced with LBmSN Figure 4
Effect of analogs of BS upon BALB/MK cells transduced with LBmSN The cells were cultured and transduced with 
LBmSN as described in Figure 1. On day 4 the media were replaced with a fresh one and BS-analogs were added at the indi-
cated concentrations. This time is indicated as day zero in the figure.
Table 3: Comparison of the vectors LBmSN and LBSN upon 
BALB/MK and NIH3T3 cells
BALB/MK NIH3T3
BS1 No antibiotic BS No antibiotic
LBmSN L D L L
L B S N L LLL
No vector D L D L
The experiment was carried out as described in the legend of the 
Figure 1. After 8 days of the transduction the cells were stained with 
Coomassie Blue for microscopic analysis. The results are 
representative of three independent experiments, which gave 
essentially the same results.
1 [BS] = In the media of the cells transduced with LBmSN and LBSN 
were added 8 µg/ml and 2 µg/ml of BS respectively, because the cells 
transduced with LBSN do not support concentrations of BS higher 
than 2 µg/ml [8].
D = dead
L = aliveBMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
Page 7 of 10
(page number not for citation purposes)
plate without BS they died in few days (Figure 7). This
result confirms the vital role of BS in bsrm  expressing
keratinocytes, as was observed with murine keratinocyte
BALB/MK cells.
The vector LBmSN also expresses neoR, which provides
resistance against geneticin. However, the transduced
keratinocytes died after the incubation with 500 µg/ml of
geneticin (Figure 6) even if the antibiotic was neutralized
by aminoglycoside phosphotransferase. This result cor-
roborates previous data that in keratinocytes the expres-
sion of bsrm gene leads to cell death. The keratinocytes
transduced with the LXSN vector [10], which was used to
construct the LBmSN vector, presented normal growth
reaching complete confluence within 8 days (not shown).
Discussion
Here we report a surprising death caused by the transduc-
tion of the murine keratinocyte cell line BALB/MK cells
with the retroviral vector LBmSN. This vector expresses
bsrm which is a modified form of bsr only in the non-cod-
ing region; consequently both genes express the same BS
deaminase. As the vector LBSN, which expresses bsr much
lower than LBmSN [8], did not kill the cells an over
expression of bsr could be responsible for the death. How-
ever, we can not discard other possibilities caused by
interactions of the bsrm gene product (mRNA or protein)
with intracellular molecules.
In some cases the Moloney murine retrovirus can cause
cell death [13]. However in our case the control retroviral
vector LXSN, which was used to construct LBmSN and
LBSN does not carry any viral genes [8], did not induce
cell death in the same culture conditions (Figure 1). Addi-
tionally the wide range of viral concentrations and cell
densities tested here (Table 1 and Figure 3) did not affect
cell death. These last results corroborate the above conclu-
sion that the death of BALB/MK cells was caused by the
expression of bsrm.
An interesting phenomenon of the death of BALB/MK
cells expressing bsrm was that those cells can be rescued if
a lethal concentration of BS (8 µg/ml to 32 µg/ml of BS
were tested) is added in the medium before three days
after transduction. It was a paradox, since the toxic antibi-
otic, BS, was able to rescue the murine keratinocyte BALB/
MK induced to die by the apparently inoffensive bacterial
bsrm gene.
BS-rescuing process of the bsrm-transduced keratinocytes
could be understood as a consequence of inhibition of the
death factor (DOKEB) production by BS. Because those
transduced keratinocytes could be maintained for long
period (at least two months) simply by changing the
medium every two days for a fresh one containing 8 µg/
Effect of BS upon the human keratinocytes transduced with  LBmSN vector Figure 6
Effect of BS upon the human keratinocytes trans-
duced with LBmSN vector On day 1, the irradiated 
PA317/LBmSN cells (30 Gy) and the human keratinocytes 
were seeded together at 3.3 × 105 and 5 × 104 cells per well 
respectively in a 12 well plate. Two days later, the medium 
was replaced with a fresh one containing the indicated con-
centrations of antibiotics. The cells were stained with Rhod-
amine B after 8 days. (A) no antibiotic; (B) 800 µg/ml G418; 
(C) 8 µg/ml BS; (D) 12 µg/ml BS; (E) 16 µg/ml BS; (F) 32 µg/
ml BS
Effect of BS upon the keratinocytes transduced with LBmSN  and selected with BS Figure 7
Effect of BS upon the keratinocytes transduced with 
LBmSN and selected with BS The keratinocytes were 
cultured and selected with 8 µg/ml BS as described in Figure 
5. When the keratinocytes reached 70 % confluence, the 
cells were divided into two parts and transferred to 2 wells 
of a 12-well plate that contained the irradiated NIH3T3 cells. 
In one well the cells were maintained without BS (A) and in 
another with 8 µg/ml BS (B). The cells were stained with 
Rhodamine B after 10 days.BMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
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ml of BS (not shown). However, we do not know if the
inhibition of DOKEB production is caused by the inhibi-
tion of protein synthesis by BS or just occupation of the
active site of the BS deaminase by BS, and consequently
inhibiting the binding of the first target molecule which is
a responsible for the induction of the death process. We
believe more in the last explanation, because if the ana-
logs of BS were added to the medium at concentrations
higher than 1 mM, cell death can be avoided (Figure 4).
The requirement of higher concentration of the analogs of
BS than BS, which requires only 19 µM to protect the bsrm
expressing BALB/MK cells, is likely due to the low affinity
of analogs for BS deaminase as expected [5].
Even though we have demonstrated that the expression of
the bsrm gene in BALB/MK is lethal, the bsrm/BS selection
system can still be used in keratinocytes. During the
selection of LBmSN-transduced keratinocytes, the initial
concentration of BS in the medium should determine a
strict range of LBmSN transduced keratinocytes, which
express not more and not less than certain levels of bsrm
gene (Figure 6). Thus, for survival of those transduced
cells AND selected with 8 µg/ml BS, the medium should
be changed every 2 days to maintain active BS concentra-
tion in the medium; otherwise, the low BS concentration
will allow the synthesis of DOKEB and in turn trigger the
death mechanism. The BALB/MK cells transduced with
LBmSN and selected with 8 µg/ml of BS should not be
challenged with concentrations much higher than those
used, since the cells expressing higher levels of bsrm gene
should have died during the previous selection. Thus, the
selected BALB/MK cells exist in a precarious situation
where either apoptosis or necrosis can be easily activated
at any unfavorable moment.
We evaluated if the lethal effect provoked by bsrm occurs
exclusively in BALB/MK cells or if this phenomenon is
general for all cell types. In this study we included normal
human primary keratinocytes and several cell lines. The
human keratinocytes are resistant to BS at concentrations
lower than 2 µg/ml and at concentrations higher than 8
µg/ml the cells die within 5 days (not shown). However,
the keratinocytes transduced with LBmSN behaved in an
opposite way. In the absence or presence of BS at low con-
centrations (lower than 2 µg/ml) the transduced cells
died, as it was observed with the BALB/MK cells trans-
duced with LBmSN. Additionally, the protection against
the death of the BALB/MK cells expressing bsrm by the
addition of a lethal concentration of BS was also observed
with the human keratinocytes expressing bsrm (Figs. 6, 7).
These results indicate that the death process triggered by
the expression of bsrm in keratinocytes should follow the
same way.
Interestingly the lethal effect provoked by bsrm appears to
be specific to keratinocytes, because none of the cell types
tested here died in our experimental conditions, except for
the human and murine keratinocytes. As the gene transfer
and expression of bsrm are an essential step to access the
lethal effect of bsrm, an alternative strategy used to verify
the gene expression and its effect was selecting the
transduced cells with 8 µg/ml BS and exposing the cells to
a fresh medium without BS. Even in such conditions the
bsrm gene did not cause any morphological alterations to
those cell types, whereas the BALB/MK cells and the
human primary keratinocytes transduced with LBmSN
and selected with BS died in a few days after removal of
the antibiotic (Figure 7). Therefore, we conclude that the
lethal activity of bsrm is specific to those keratinocytes.
The analysis of DOKEB through exclusion molecular
chromatography showed that the factor has a molecular
weight equivalent of two amino acids (not shown). There-
fore, DOKEB should not be BS deaminase, or even any
protein. Further purification and molecular analysis are in
progress.
In this study we demonstrated only in vitro that the expres-
sion of the reporter gene bsrm has a lethal effect on kerat-
inocytes. However as most of the gene therapy
experiments using keratinocytes are carried out ex vivo
with retroviral vectors, our finding has a very important
meaning. Because the cells transduced with retroviral vec-
tor carrying bsrm and selected with BS can survive until the
antibiotic is maintained in the medium, but when those
cells are returned to the own organism, which has no BS
in it, DOKEB will be produced and can provoke serious
lesion in the body.
By this study we also point out the danger of using heter-
ologous genes, in particular those isolated from the
microorganisms, in gene transfer and gene therapy exper-
iments without proper controls.
Conclusions
We demonstrated in this study that the expression of the
reporter gene bsrm has a lethal effect on the murine BALB/
MK cell line and human primary keratinocytes. It is likely
over expression of the BS deaminase gene is responsible
for the death. The death appears to be mediated by a fac-
tor, which is secreted by the BALB/MK transduced cells. By
this study we point out the danger of using heterologous
genes, in particular those isolated from the microorgan-
isms, in gene transfer experiments without proper
controls.BMC Biotechnology 2004, 4:29 http://www.biomedcentral.com/1472-6750/4/29
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Methods
Retroviral vectors
The retroviral vectors used in the present study are based
on the Moloney murine leukemia virus: LXSN [10], LBSN
[8] and LBmSN [8]. The letters L, X, S, N, B, Bm of those
vectors represent retroviral LTR promoter, cloning site,
promoter of simian virus SV40, neomycine resistance
gene (neoR), bsr and bsrm, respectively. The LBSN and
LBmSN vectors were constructed inserting the bsr and bsrm
genes into the Hpa I site of LXSN, which is located in the
cloning site [8].
Cell line culture
The amphotropic retrovirus producing cell clones PA317/
LBmSN, PA317/LBSN and PA317/LXSN [8], the murine
fibroblast NIH3T3, HeLa, the human colorectal carci-
noma cell lines LISP-A10 and LISP-E11 [14] were cultured
in Dulbecco's modified Eagle medium (DMEM) with high
glucose (4.5 g/ml), supplemented with 2 mM glutamine,
200 U/ml penicillin, 200 µg/ml streptomycin and 10 %
fetal bovine serum (FBS) (InVitrogen, São Paulo, Brazil)
at 37°C in a humidified atmosphere with 5 % CO2. The
mouse fibroblast CCL-92 (ATCC) was cultured as above,
except that the FBS was replaced with the bovine calf
serum (InVitrogen, São Paulo, Brazil). For the culture of
the murine keratinocyte BALB/MK cells (kindly provided
by Dr Stuart A. Aaronson, The Derald H. Ruttenberg Can-
cer Center, New York, NY), EMEM (Biofluids, Rockville,
MD) containing 0.05 mM CaCl2, 10 ng/ml of EGF and 10
% FBS was used.
The human colorectal carcinoma cell line HCT-8 and the
murine melanoma cell line B16F10 [15] were cultured in
RPMI 1640 (InVitrogen, São Paulo, Brazil) supplemented
with 0.2 % NaHCO3, HEPES 10 mM, pH 7.3, 40 µg/ml
garamicine and 10 % FBS at 37°C in a humidified atmos-
phere with 5 % CO2.
Rat primary smooth muscle cell culture and viral 
transduction
A primary culture of rat smooth muscle cells was prepared
as previously described [12], digesting the Wistar isogenic
rat aortas enzymatically. These cells were characterized
immunocytochemically using antibodies against α-actin
(Boehringer Mannheim, São Paulo, Brazil) for SMC posi-
tive staining and von Willebrand factor (Boehringer Man-
nheim, São Paulo, Brazil) for SMC negative and
endothelial cell positive staining [12]. Only early-passage
smooth muscle cells were exposed for 24 h to virus
harvested from PA317/LBmSN cells for a period of 24 h in
the presence of Polybrene (8 µg/ml, Sigma)
Transduction of mammalian cell lines with retroviral 
vectors
The target cells were seeded on a 24 well plate at 1 × 104
cells per well with an appropriate medium as mentioned
above. In parallel, 1 × 106 of virus producing cells (PA317/
LBmSN, PA317/LBSN or PA317/LXSN) were seeded in a
25 cm2 flask. After 24 h, the media from the target cells
and the virus producing cells were replaced with a fresh
one used for target cells. On the next day, the media of the
target cells were replaced with 500 µl of the virus solution
collected from the supernatant of the PA317/LBmSN cell
culture and filtered in 0.45 µm syringe filter. Polybrene
was added to the virus solution at the final concentration
of 8 µg/ml. One day after the infection, the media were
replaced with a fresh one, maintained in the CO2 incuba-
tor and the cells were observed using a microscope
everyday.
In parallel, after two days of the infection, a new set of the
transduced cells was split and only 1/10 part of the cells
was maintained in the same well. The BS antibiotic was
added to the wells at concentrations between 0 to 32 µg/
ml. When the cells reached confluence they were split and
transferred to two wells of a 12-well plate. To one well, BS
was added at the concentration used for selection, and
another well was maintained without BS. The cells were
observed under the microscope everyday.
Human primary keratinocytes culture and viral 
transduction
Normal human keratinocytes from healthy adult volun-
teers were obtained by biopsy, cut in small pieces and
incubated in a trypsin solution (0.05 %) containing 0.01
% EDTA at 37°C for 3 h under constant agitation. Every
30 min the detached cells were transferred to a new 75
cm2 flask containing 2 × 106 cells of the irradiated CCL-92
cells (60 Gy) as a feeder-layer. The medium used for the
culture of the keratinocytes was composed of DMEM and
Ham's F12 (2:1) containing 10 % FBS, 4 mM glutamine,
50 IU/ml streptomycin- penicillin, 0.18 mM adenine, 5
µg/ml insulin, 5 µg/ml transferrin, 0.4 µg/ml hydrocorti-
sone, 0.1 nM choleric toxin and 20 pM triiodotyronin
[11]. The medium was replaced every 2 to 3 days with a
fresh one containing 10 ng/ml EGF. The cells were main-
tained in a humidified atmosphere with 5 % CO2.
For retroviral transduction, the packaging clones PA317/
LBmSN and PA317/LXSN were irradiated with 30 Gy and
used as a feeder-layer for the prepared previously kerati-
nocyte cultures.
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The lethal effect of the supernatant from the BALB/MK cells  transduced with LBmSN Figure 5
The lethal effect of the supernatant from the BALB/
MK cells transduced with LBmSN On day 1, BALB/MK 
cells were seeded on a 6 well plate at 4 × 104 cells/well, and 1 
× 106 cells of the virus producing cell lines PA317/LBmSN 
and PA317/LXSN were seeded in 25 cm2 flasks. On day 2, 
the media of the PA317 cell clones were replaced with the 
EMEM supplemented with 10 % FBS and without EGF. On 
day 3, the media of PA317 cells containing virus were har-
vested, centrifuged at 10,000 rpm per 1 min in Eppendorf 
centrifuge. The media of BALB/MK cells were replaced by 2 
ml of virus solution and complemented with 5 ng/ml of EGF 
and 8 µg/ml of Polybrene. In parallel, 1 × 104 BALB/MK cells 
were seeded on a 24 well plate. On day 4, the media were 
replaced by fresh ones. On day 5, the medium of BALB/MK 
cells was replaced by 0.5 ml of the medium of the LBmSN 
transduced BALB/MK cells, which was previously centrifuged 
at 10,000 rpm/ 1 min. After 7 days, the cells were photo-
graphed (X 200). The results are representative of at least 
three experiments, which gave essentially the same results. 
(A) The BALB/MK cells incubated with supernatant of BALB/
MK cells transduced with LXSN; (B) The BALB/MK cells 
incubated with supernatant of BALB/MK cells transduced 
with LBmSN.